| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00125-015-3637-1 |
| P698 | PubMed publication ID | 26026653 |
| P50 | author | Martin Bødtker Mortensen | Q55856237 |
| Jacob Fog Bentzon | Q57070223 | ||
| Christina Christoffersen | Q58929492 | ||
| Rozh H Al-Mashhadi | Q59206013 | ||
| P2093 | author name string | Erling Falk | |
| Torben Larsen | |||
| Martin M Bjørklund | |||
| P2860 | cites work | Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes | Q22250887 |
| Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus | Q24202505 | ||
| Dyslipidemia and vascular dysfunction in diabetic pigs fed an atherogenic diet | Q28377461 | ||
| Effects of streptozotocin-induced diabetes and insulin treatment on the hypothalamic melanocortin system and muscle uncoupling protein 3 expression in rats | Q28564538 | ||
| Is glycaemia or insulin dose the stronger risk factor for coronary artery disease in type 1 diabetes? | Q33833060 | ||
| Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions | Q33916802 | ||
| Akt pathway is hypoactivated by synergistic actions of diabetes mellitus and hypercholesterolemia resulting in advanced coronary artery disease | Q34150587 | ||
| Effect of aleglitazar on cardiovascular outcomes after acute coronary syndrome in patients with type 2 diabetes mellitus: the AleCardio randomized clinical trial | Q34660831 | ||
| Predictors of incident albuminuria in the Framingham Offspring cohort | Q35404652 | ||
| Regulation of hepatic LDL receptors by mTORC1 and PCSK9 in mice | Q35858148 | ||
| Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on Cardiovascular Complications of Type 1 Diabetes Mellitus | Q36176985 | ||
| Type 1 diabetes and coronary artery disease | Q36634829 | ||
| Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study | Q37054992 | ||
| Impaired renal function further increases odds of 6-year coronary artery calcification progression in adults with type 1 diabetes: the CACTI study | Q37106389 | ||
| Type 1 diabetes, hyperglycaemia, and the heart | Q37172723 | ||
| The effect of intensive glycemic treatment on coronary artery calcification in type 1 diabetic participants of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study | Q37239766 | ||
| Increased atherosclerosis in streptozotocin-induced diabetic mice | Q37353969 | ||
| Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions | Q37486465 | ||
| Atherosclerotic lesions in mouse and man: is it the same disease? | Q37777606 | ||
| Why does diabetes increase atherosclerosis? I don't know! | Q39951404 | ||
| Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts | Q41009444 | ||
| Diabetes-induced accelerated atherosclerosis in swine | Q43651836 | ||
| Studies on the energy metabolism of pig red cells. I. The limiting role of membrane permeability in glycolysis | Q43841864 | ||
| Glycemia (or, in women, estimated glucose disposal rate) predict lower extremity arterial disease events in type 1 diabetes | Q43879632 | ||
| Lipoprotein lipase deficiency and CETP in streptozotocin-treated apoB-expressing mice | Q44007466 | ||
| Increased atherosclerosis in diabetic dyslipidemic swine: protection by atorvastatin involves decreased VLDL triglycerides but minimal effects on the lipoprotein profile | Q44168286 | ||
| Reduction of cardiac functional reserve and elevation of aortic stiffness in hyperlipidemic Yucatan minipigs with systemic and coronary atherosclerosis | Q44344010 | ||
| Effects of streptozotocin-induced diabetes in apolipoprotein AI deficient mice | Q44716932 | ||
| Risk factors for coronary heart disease in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study | Q44745070 | ||
| Familial hypercholesterolemia and atherosclerosis in cloned minipigs created by DNA transposition of a human PCSK9 gain-of-function mutant | Q44937777 | ||
| Association between glycosylated hemoglobin level and cardiovascular and all-cause mortality in type 1 diabetes | Q44994691 | ||
| Effect of streptozotocin-induced hyperglycemia on lipid profiles, formation of advanced glycation endproducts in lesions, and extent of atherosclerosis in LDL receptor-deficient mice | Q45120387 | ||
| Overexpression of hyaluronan in the tunica media promotes the development of atherosclerosis | Q45261400 | ||
| Rosiglitazone attenuates atherosclerosis in a model of insulin insufficiency independent of its metabolic effects | Q46601696 | ||
| Decreased lipoprotein clearance is responsible for increased cholesterol in LDL receptor knockout mice with streptozotocin-induced diabetes | Q46696587 | ||
| Development of atherosclerosis in the diabetic BALB/c mice. Prevention with Vitamin E administration | Q46700742 | ||
| The thromboxane A2 receptor antagonist S18886 prevents enhanced atherogenesis caused by diabetes mellitus | Q46783978 | ||
| The cis-9,trans-11 isomer of conjugated linoleic acid (CLA) lowers plasma triglyceride and raises HDL cholesterol concentrations but does not suppress aortic atherosclerosis in diabetic apoE-deficient mice | Q46940719 | ||
| Effect of hyperglycemia and hyperlipidemia on atherosclerosis in LDL receptor-deficient mice: establishment of a combined model and association with heat shock protein 65 immunity. | Q51555624 | ||
| Intracoronary ultrasound examinations reveal significantly more advanced coronary atherosclerosis in people with type 1 diabetes than in age- and sex-matched non-diabetic controls | Q57740227 | ||
| Glycemic Control and Excess Mortality in Type 1 Diabetes | Q59587753 | ||
| Intestinal and Hepatic Cholesterogenesis in Hypercholesterolemic Dyslipidemia of Experimental Diabetes in Dogs | Q67791450 | ||
| Contributions of Absorbed Dietary Cholesterol and Cholesterol Synthesized in Small Intestine to Hypercholesterolemia in Diabetic Rats | Q68434926 | ||
| Reduced atherogenesis in cholesterol-fed diabetic rabbits. Giant lipoproteins do not enter the arterial wall | Q68446303 | ||
| Hormonal regulation of low-density lipoprotein (LDL) receptor activity in human hepatoma Hep G2 cells. Insulin increases LDL receptor activity and diminishes its suppression by exogenous LDL | Q69827315 | ||
| Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial | Q72198055 | ||
| Streptozotocin-induced diabetes in human apolipoprotein B transgenic mice. Effects on lipoproteins and atherosclerosis | Q73251589 | ||
| Coronary calcium in adults with type 1 diabetes: a stronger correlate of clinical coronary artery disease in men than in women | Q74256386 | ||
| Coronary microvascular dysfunction in a porcine model of early atherosclerosis and diabetes | Q85067293 | ||
| P433 | issue | 8 | |
| P921 | main subject | hypercholesterolemia | Q762713 |
| atherosclerosis | Q12252367 | ||
| P304 | page(s) | 1926-1936 | |
| P577 | publication date | 2015-05-31 | |
| P1433 | published in | Diabetologia | Q5270140 |
| P1476 | title | Diabetes with poor glycaemic control does not promote atherosclerosis in genetically modified hypercholesterolaemic minipigs. | |
| P478 | volume | 58 |
| Q37171845 | A single injection of gain-of-function mutant PCSK9 adeno-associated virus vector induces cardiovascular calcification in mice with no genetic modification |
| Q49893263 | Absence of Nicotinamide Nucleotide Transhydrogenase in C57BL/6J Mice Exacerbates Experimental Atherosclerosis. |
| Q51245649 | Alloxan-induced diabetes exacerbates coronary atherosclerosis and calcification in Ossabaw miniature swine with metabolic syndrome. |
| Q49952246 | Animal models of obesity and diabetes mellitus |
| Q89669823 | Combating atherosclerosis with targeted Diosmin nanoparticles-treated experimental diabetes |
| Q37083092 | Does Elevated Glucose Promote Atherosclerosis? Pros and Cons |
| Q50107614 | Genetically engineered pigs as models for human disease |
| Q36086591 | Göttingen minipig model of diet-induced atherosclerosis: influence of mild streptozotocin-induced diabetes on lesion severity and markers of inflammation evaluated in obese, obese and diabetic, and lean control animals |
| Q55355643 | Hyperglycemia does not affect tissue repair responses in shear stress-induced atherosclerotic plaques in ApoE-/- mice. |
| Q38594603 | Large animal models of atherosclerosis--new tools for persistent problems in cardiovascular medicine |
| Q36738466 | Models for preclinical studies in aging-related disorders: One is not for all. |
| Q51556455 | Ossabaw Pigs With a PCSK9 Gain-of-Function Mutation Develop Accelerated Coronary Atherosclerotic Lesions: A Novel Model for Preclinical Studies. |
| Q64951302 | Quantitative applications in positron emission tomography achieved through signal modelling. |
| Q92771839 | Serum insulin levels are associated with vulnerable plaque components in the carotid artery: the Rotterdam Study |
| Q42367561 | The PCSK9 revolution and the potential of PCSK9-based therapies to reduce LDL-cholesterol |
| Q39298787 | The emerging role of microdialysis in diabetic patients undergoing amputation for limb ischemia |
| Q64267632 | Tissue volume and activity mapping using total intensity projection of PET/CT images |
Search more.